{
    "ticker": "AYTU",
    "name": "Aytu BioPharma, Inc.",
    "description": "Aytu BioPharma, Inc. is a biopharmaceutical company focused on developing and commercializing novel products in the fields of urology and other therapeutic areas. Founded in 2015 and headquartered in Englewood, Colorado, Aytu aims to address unmet medical needs through a combination of proprietary and acquired products. The company is known for its flagship product, the prescription medication Natesto, which is the only FDA-approved nasal testosterone replacement therapy for men with low testosterone levels. Aytu\u2019s product portfolio also includes other therapeutics and diagnostics, primarily targeting conditions related to male health, including fertility and hormone replacement. The company is committed to advancing science and innovation to improve patient outcomes and enhance the quality of life for those affected by various health conditions. Aytu BioPharma is actively working on expanding its pipeline and establishing partnerships to further broaden its therapeutic offerings and market reach. With a dedicated team of professionals and a focus on strategic growth, Aytu is poised to make a significant impact in the biopharmaceutical industry.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Englewood, Colorado, USA",
    "founded": "2015",
    "website": "https://www.aytubio.com",
    "ceo": "Josh Disbrow",
    "social_media": {
        "twitter": "https://twitter.com/AytuBioPharma",
        "linkedin": "https://www.linkedin.com/company/aytu-biopharma/"
    },
    "investor_relations": "https://ir.aytubio.com",
    "key_executives": [
        {
            "name": "Josh Disbrow",
            "position": "CEO"
        },
        {
            "name": "Mark L. Sirgo",
            "position": "President"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceuticals",
            "products": [
                "Natesto",
                "ZolpiMist"
            ]
        },
        {
            "category": "Diagnostics",
            "products": [
                "Testosterone Diagnostic Tests"
            ]
        }
    ],
    "seo": {
        "meta_title": "Aytu BioPharma, Inc. | Innovative Biopharmaceutical Solutions",
        "meta_description": "Explore Aytu BioPharma, Inc., a biopharmaceutical company dedicated to developing innovative solutions in urology and male health. Learn about their products and commitment to patient care.",
        "keywords": [
            "Aytu BioPharma",
            "Biopharmaceuticals",
            "Urology",
            "Natesto",
            "Testosterone Replacement",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What does Aytu BioPharma specialize in?",
            "answer": "Aytu BioPharma specializes in developing and commercializing novel products in urology and other therapeutic areas."
        },
        {
            "question": "What is Natesto?",
            "answer": "Natesto is the only FDA-approved nasal testosterone replacement therapy for men with low testosterone levels."
        },
        {
            "question": "When was Aytu BioPharma founded?",
            "answer": "Aytu BioPharma was founded in 2015."
        },
        {
            "question": "Where is Aytu BioPharma located?",
            "answer": "Aytu BioPharma is headquartered in Englewood, Colorado, USA."
        },
        {
            "question": "Who is the CEO of Aytu BioPharma?",
            "answer": "Josh Disbrow is the CEO of Aytu BioPharma, Inc."
        }
    ],
    "competitors": [
        "VYGR",
        "CERS",
        "HGEN"
    ],
    "related_stocks": [
        "PFE",
        "JNJ",
        "ABBV",
        "MRK"
    ]
}